GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Pre-Tax Income

LakeShore Biopharma Co (LakeShore Biopharma Co) Pre-Tax Income : $-43.44 Mil (TTM As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. LakeShore Biopharma Co's pretax income for the six months ended in Sep. 2023 was $-24.03 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2023 was $-43.44 Mil. LakeShore Biopharma Co's pretax margin was -64.21%.

During the past 3 years, LakeShore Biopharma Co's highest Pretax Margin was -20.10%. The lowest was -67.85%. And the median was -21.00%.


LakeShore Biopharma Co Pre-Tax Income Historical Data

The historical data trend for LakeShore Biopharma Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Pre-Tax Income Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23
Pre-Tax Income
-26.78 -15.93 -20.95

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Pre-Tax Income Get a 7-Day Free Trial -6.10 -9.72 -1.50 -19.42 -24.03

Competitive Comparison of LakeShore Biopharma Co's Pre-Tax Income

For the Biotechnology subindustry, LakeShore Biopharma Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LakeShore Biopharma Co's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Pre-Tax Income falls into.



LakeShore Biopharma Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

LakeShore Biopharma Co's Pretax Income for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-16.443+-0.026+-4.478+0+0
=-20.95

LakeShore Biopharma Co's Pretax Income for the quarter that ended in Sep. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-23.107+0.857+-2.045+0.268+0
=-24.03

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-43.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LakeShore Biopharma Co  (NAS:LSB) Pre-Tax Income Explanation

LakeShore Biopharma Co's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-24.027/37.421
=-64.21%

During the past 3 years, LakeShore Biopharma Co's highest Pretax Margin was -20.10%. The lowest was -67.85%. And the median was -21.00%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LakeShore Biopharma Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Traded in Other Exchanges
Address
38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.